Innoviva (INVA) Revenue (2011 - 2026)

Innoviva's Revenue history runs 16 years deep, the most recent figure standing at $98.0 million for Q1 2026.

• Quarterly Revenue rose 10.56% year-over-year to $98.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $496.1 million (up 8.63% YoY) and the FY2025 annual result came in at $411.3 million, up 14.67% from the prior year.
• Revenue was $98.0 million for Q1 2026 at Innoviva, up from $1.1 million in the prior quarter.
• Across five years, Revenue topped out at $296.7 million in Q3 2025 and bottomed at $1.1 million in Q4 2022.
• A 5-year average of $85.8 million and a median of $4.1 million in 2022 frame the typical range for Revenue.
• Annual changes were most pronounced in 2023 — Revenue tumbled 31.18% — and 2025, when it soared 3453.81%.
• Innoviva's Revenue stood at $1.1 million in 2022, then soared by 45.39% to $1.5 million in 2023, then declined by 19.18% to $1.2 million in 2024, then dropped by 12.15% to $1.1 million in 2025, then surged by 8931.71% to $98.0 million in 2026.
• Business Quant data shows INVA's Revenue at $98.0 million in Q1 2026, $1.1 million in Q4 2025, and $296.7 million in Q3 2025.